New Century Healthcare Adjusts Evaluation Amidst Evolving Financial Metrics

New Century Healthcare Holding Co., Ltd., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced an adjustment in evaluation. This revision reflects changes in the company's underlying financial metrics, which are critical for assessing its market position.
The company has reported a sales growth of 2.11% over the past five years, alongside a notable EBIT growth of 14.32%. The average EBIT to interest ratio stands at 4.91, indicating a stable capacity to cover interest expenses. Additionally, New Century Healthcare maintains a debt to EBITDA ratio of 0.0, suggesting a lack of debt relative to its earnings before interest, taxes, depreciation, and amortization.

The net debt to equity ratio is recorded at -0.53, which may indicate a strong equity position. The sales to capital employed ratio is 1.15, reflecting efficient use of capital. The tax ratio is at 34.29%, and the dividend payout ratio is 20.79%. Notably, the company has no pledged shares or institutional holdings, and its average return on capital employed (ROCE) is 26.41%, with a return on equity (ROE) of 9.25%.

This evaluation adjustment highlights the evolving financial landscape of New Century Healthcare Holding Co., Ltd.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.